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ABSTRACT
The relationship between virion protein maturation
and genomic RNA dimerization of human immuno-
deficiency virus type 1 (HIV-1) remains incompletely
understood. We have constructed HIV-1 Gag
cleavage site mutants to enable the steady state
observation of virion maturation steps, and pre-
cisely study Gag processing, RNA dimerization,
virion morphology and infectivity. Within the virion
maturation process, the RNA dimer stabilization
begins during the primary cleavage (p2-NC) of Pr55
Gag. However, the primary cleavage alone is not
sufficient, and the ensuing cleavages are required
for the completion of dimerization. From our obser-
vations, the increase of cleavage products may not
put a threshold on the transition from fragile to
stable dimeric RNA. Most of the RNA dimerization
process did not require viral core formation, and par-
ticle morphology dynamics during viral maturation
did not completely synchronize with the transition
of dimeric RNA status. Although the endogenous
virion RT activity was fully acquired at the initial
step of maturation, the following process was
necessary for viral DNA production in infected cell,
suggesting the maturation of viral RNA/protein
plays critical role for viral infectivity other than RT
process.
INTRODUCTION
The genome of retrovirus such as human immunodeﬁ-
ciency virus type 1 (HIV-1) is a single-stranded, positive-
sense RNA. The viral genome always occurs as a dimer in
virus particles, and the interaction is non-covalent since
heating easily dissociates puriﬁed dimeric genomes into
monomers. Genomic RNA dimerization is believed to be
a crucial step for the life cycle of retroviruses. Template
strand switching between two genomes during reverse
transcription is often observed in the retroviral lifecycle
(1). It is likely that the presence of two genomes in one
virion helps the virus survive by providing genetic variety
for their progeny (2). However, this may not fully explain
why the virion is required to carry two identical RNAs in
spite of severe space limitation, since retroviruses with
little sequence variety such as HTLV-1 (3) are also
dimeric. Identiﬁcation of cis-acting signals for retrovirus
genome dimerization, called the dimer linkage structure
(DLS), was initially attempted in an in vitro assay (4–8).
The proposed DLS regions of HIV-1 is located within the
untranslated region between LTR and the gag gene (4,9).
Although the DLS on viral RNA is suggested to be
involved in dimer formation and its close relationship to
the packaging signal has been studied (2), there remains
incompletely understood issues about the overall mechan-
isms and the precise nature of retroviral genome
dimerization.
The retrovirus dynamically converts the morphology of
its particle interior during particle release, termed ‘matur-
ation’. Maturation changes virion morphology from the
immature particle, called donut-shaped particle, to the
mature virion; a particle lined with viral matrix proteins
containing a condensed core composed of a viral capsid
shell caging ribonucleoprotein (RNP) complex, comprised
of viral RNA, nucleocapsid and enzymes (10). Maturation
prepares the virus for infection of adjacent hosts and is
inevitably essential for particle infectivity. Although many
aspects about how the process of virion maturation
contributes to achieving infectivity remain unclear, it is a
well-accepted idea that viral RNA within the virion forms
a stable and uniform dimer only after complete virion
maturation. Obviously, viral protease (PR) activity to
process Gag precursor protein (Pr55) is required for
stable genomic RNA dimerization in the virion. It has
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protein, have RNA chaperone activity and are required
for the proper formation of dimeric RNA in the virion
(11,12). A defect in its capability to stably dimerize
genomic RNA was found in a PR virus (13,14), which
led to a hypothesis that one or more Gag cleavage products
help form or stabilize genomic RNA dimers. There are ﬁve
cleavage sites in the HIV-1 Gag protein and the sequential
processing of Gag by PR has been discussed so far (15).
Some preceding studies suggested that speciﬁc Gag
cleavage sites or protein regions contribute to viral
genome dimerization (16–20). In light of these ﬁndings,
we constructed two sets of Gag mutants which could rep-
resent cleavage intermediates, effectively snapshooting the
process of virion maturation in this study. To systematic-
allyclarify thedynamic correlationbetweenviralRNAand
protein maturation in viral life cycle, virion protein,
genomic RNA, virion morphology and infectivity of
these mutants were examined comprehensively. We found
that NC maturation is critical for the accomplishment of
RNA dimerization and viral infectivity, but unnecessary
for proper reverse transcription of viral RNA and virion
maturation. The mutual relationship between viral protein
and RNA maturation was discussed for a further under-
standing of the retroviral life cycle.
MATERIALS AND METHODS
Constructs
The plasmid pNLNh (21), which contains a 4-base inser-
tion mutation to abrogate Env protein expression on the
env gene of HIV-1 proviral clone pNL4-3 (22), was used as
the wild-type (WT) and as the progenitor for the mutant
constructs described. The amino acid sequence of the Gag
cleavage sites and the constitution of the mutants are
summarized in Figure 1. The Gag cleavage site mutants
MA/CA, CA/p2, p2/NC, NC/p1 and p1/p6, were con-
structed according to the previous reports (16,23) using
PCR stitch mutagenesis (24). The double cleavage site
mutant Step2, containing CA/p2 and NC/p1 mutations,
was constructed by introducing N432T amino acid substi-
tution to the CA/p2 mutant. The triple cleavage site
mutant Step1.1, containing MA/CA, CA/p2 and NC/p1
mutations, was constructed by introducing Y132I amino
acid substitution to the Step2 mutant. The quadruple
cleavage site mutant Step1, containing all four cleavage
site mutations except p2/NC, was constructed by intro-
ducing F448S amino acid substitution to the Step1.1
mutant. The quintuple cleavage site mutant Step0, con-
taining all Gag cleavage sites mutations, was constructed
by introducing M377V amino acid substitution to the
Step1 mutant. The HIV-1 proviral mutant MS172,
which lacks PR activity, was previously described (25).
Cell culture and transfection
293T cells (26) were maintained in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal calf
serum, penicillin and streptomycin. The cells were trans-
fected with the calcium phosphate method (27). To
recover virus particles, 5mg of plasmid DNA was used
to transfect the cells in a 100mm dish. Production of par-
ticles containing a mixture of quadruple and quintuple
Gag cleavage sites mutants was achieved by co-
transfection of Step1 and 0 plasmids in various ratios.
Virus puriﬁcation
Supernatants of transfected cells were collected 72h
post-transfection and treated with DNase I for elimination
Figure 1. Gag-cleavage site mutations of HIV-1. (A) Summary of the
mutations used in this study. Upper ﬁgure represents HIV-1 Gag and
its cleavage site sequences. The slashes represent the position of
cleavage and the numbers beneath the letters designate amino acid
positions in Pr55. The correlation between the mutation and the
mutants constructed are summarized in the table. Details on the mu-
tations Y132I, M377V, N432T and F448S have been reported (23), as
well as the L363I and M367I mutations (16). The M367I mutation was
introduced to block an HIV-1 PR-mediated cryptic cleavage site within
the p2 protein because this cryptic cleavage has been reported to occur
when proteolytic cleavage between CA and p2 was inhibited by L363I
mutation. (B) Schematic representations of the single Gag-cleavage site
mutants. Shaded boxes represent fusion proteins which resulted from
the mutations. (C) Detection of HIV-1 protein produced in pelleted
virions by western blotting with various anti-Gag antibodies.
Positions of Gag proteins and precursors were indicated. The asterisks
indicate aberrant proteins (‘Results’ section).
Nucleic Acids Research,2011, Vol.39, No. 8 3405of plasmid (28). Then they were centrifuged for 20min at
4 C and 1570g to remove cellular debris. The clariﬁed
supernatants were concentrated by ultracentrifugation
through a 20% sucrose cushion in PBS by using an
Optima L-100XP ultracentrifuge and a SW41Ti rotor
(Beckman Coulter Inc., Brea, CA, USA) at 151000g for
45min at 4 C.
Western blotting analysis
Equal amounts of viral lysate from each sample were re-
suspended in NuPAGE LDS Sample Buffer (Invitrogen,
Carlsbad, CA, USA). Proteins were resolved by SDS–
polyacrylamide gels (4–12%) and transferred to nitrocel-
lulose membranes by using iBlot (Invitrogen). The mem-
branes were treated with mouse anti-MA monoclonal
antibody (29), mouse anti-CA monoclonal antibody
(Advanced Biotechnologies Inc., Columbia, MD, USA),
rabbit anti-NC polyclonal antibody, and rabbit anti-p6
polyclonal antibody (30). ECL Western blotting detection
reagents (Nacalai Tesque, Kyoto, Japan) were used for
signal detection with horseradish peroxidase conjugated
anti-mouse and anti-rabbit IgG (Vector Laboratories,
Burlingame, CA, USA). Chemiluminescence was
visualized by LAS-1000 (Fujiﬁlm, Tokyo, Japan) accord-
ing to the manufacturer’s protocols.
Isolation of viral RNA
Puriﬁed virions were resuspended in 150ml of lysis buffer
(50mM Tris–HCl pH 7.5, 100mM NaCl, 10mM EDTA,
1% SDS). Viral lysate was treated with 0.2mg/ml protein-
ase K (Invitrogen) at room temperature for 60min,
followed by Tris–EDTA-saturated phenol–chloroform ex-
traction, chloroform extraction and ethanol precipitation
to collect puriﬁed viral RNA.
Native northern blotting analysis
Pelleted RNA was resuspended in T-buffer (31), and the
thermostability of dimeric viral RNA was determined by
incubating RNA aliquots for 10min at 25, 35, 40, 44, 48
and 52 C (Figure 2), or 25, 35, 40, 45 and 50 C (Figure 3).
One quarter of the total amount of puriﬁed viral RNA
was applied for each sample. The proportions of the
dimers and monomers were measured by electrophoresis
at room temperature on a non-denaturing 0.7% agarose
gel in 0.5X Tris–borate–EDTA buffer. Field inversion gel
electrophoresis was performed for better separation of
large RNA molecules. The conditions for ﬁeld inversion
gel electrophoresis were as follows: forward, 5 V/cm and
0.6 s; reverse, 5 V/cm and 0.1 s. The agarose gel was then
treated with 10% formaldehyde at 65 C for 30min before
Figure 2. Thermal stability of Viral RNA dimers of single Gag-cleavage site mutants. (A) Virion RNA proﬁles detected by northern blotting in a
native agarose gel. Viruses were prepared by transfection of 293T cells with the wild-type (WT; pNLNh) virus or its derivative mutants. Aliquots of
RNA extracted from virions were resuspended in T-buffer and incubated for 10min in parallel reactions. The temperatures in which aliquots were
incubated are indicated for each lane. (B) A schematic ﬁgure for dimer/monomer calculation. Each lane of the blot was separated into two parts,
dimer or larger and monomer or smaller molecules as shown in boxes with dashed lines. The relative amounts of monomeric and total RNAs in each
lane were quantitated with ImageGauge, and the percentage of the total represented by monomeric RNA was calculated for each RNA sample.
(C) Thermal dissociation kinetics of RNA dimers. Results are the average of three independent experiments. Error bars represent SEM.
3406 Nucleic Acids Research, 2011,Vol.39, No. 8being washed with H2O three times, and the RNA was
blotted electrically onto a Hybond-N+ nylon membrane
(GE healthcare, Chalfont St Giles, UK).
RNA northern hybridization analysis was performed as
described previously (31). The plasmid pT7pol (31) and T7
RNA polymerase (Takara Bio Inc., Shiga, Japan) were
used to synthesize the riboprobe, which speciﬁcally
detects unspliced viral RNAs, for northern hybridization.
Hybridization was carried out in the presence of Rapid-
Hyb buffer (GE healthcare). Membranes were washed
extensively with 0.1  SSC (1  SSC was comprised of
15.0mM NaCl and 15mM sodium citrate [pH 7.0])
0.1% SDS at 70 C. In experiments designed to assess
the conversion of dimers to monomers, the relative
amounts of both RNA species were quantitated with a
FLA5000 image analyzer and BAS imaging plate
(Fujiﬁlm). To characterize the proﬁle of genomic RNA,
a lane on the blot was scanned by ImageGauge software
(Fujiﬁlm) and the signal intensity and distance migrated
from each well were measured.
Figure 3. The mutants to mimic sequential processing of HIV-1 Gag. (A) Schematic representations of the mutants. CA/p2 and NC/p1 mutants were
added for reference. Shaded boxes represent fusion proteins which resulted from the mutations. (B) Detection of HIV-1 protein produced in pelleted
virions by western blotting with various anti-Gag antibodies. Positions of Gag proteins and precursors are indicated. (C) Raw virion RNA proﬁles
detected by northern blotting in a native agarose gel as in Figure 2. (D) Thermal dissociation kinetics of RNA dimers. The experiments were similarly
performed as described in Figure 2. Results are the average of three to ﬁve independent experiments. Error bars represent SEM.
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293T cells were transfected with appropriate plasmids.
Supernatants were collected 36h post-transfection and
ultracentrifuged for 30min at 4 C and 49000g through a
20% sucrose cushion. Pellets were washed twice with
0.15M phosphate buffered saline (PBS, pH 7.2) and ﬁxed
with 2% glutaraldehyde in PBS at 4 C for 120min. The
ﬁxed pellets were washed ﬁve times with PBS. The ﬁxed
pellets were further ﬁxed in 1% osmium tetroxide in the
same buffer at 4 C for 60min, washed in the buffer,
dehydrated in a graded ethanol series and embedded in
epoxy resin (Plain Resin; Nisshin-EM, Tokyo, Japan).
Ultrathin sections were cut using a Porter Blum
ultramicrotome (Sorvall MT-5000; Du Pont, Newton,
CT, USA) and mounted on a copper grid (300 mesh) sup-
ported by a carbon-coated collodion ﬁlm. Finally, the
sections were double stained with uranyl acetate and lead
citrate. All the sections were observed under a transmission
electron microscope (H-7650; Hitachi, Tokyo, Japan) with
an accelerating voltage of 80kV. Electron micrographs
were obtained at 10000-fold magniﬁcation.
Endogenous RT assay
Puriﬁed virions were suspended with PBS( ) and endogen-
ous RT assay was performed essentially as previously
described (32). Aliquots of virus suspensions were
incubated in 30ml of endogenous reverse transcription
reaction mixture (0.01% Triton X-100, 50mM NaCl,
50mM Tris–HCl [pH 8.0], 10mM dithiothreitol, 5mM
MgCl2, 100mM each dATP, dCTP, dGTP and dTTP). As
anegativecontrol,reactionswithoutdTTPwereperformed
in parallel. After 2h of incubation at 37 C, the reaction
was terminated by addition of 120ml of stop mix (50mg
of proteinase K per ml, 20mg of tRNA per ml, 1.5mM
EDTA [pH 8.0]). After incubation at 60 C for 1h, the
proteinase K was heat-inactivated by incubation at 95 C
for 15min. 4ml aliquots of the reaction mixtures were
subjected to real-time PCR analysis. A portion of virion
suspension with PBS ( ) was dispensed and viral RNA
was puriﬁed directly by High Pure Viral RNA Kit
(Roche Applied Science, Mannheim, Germany). Viral
RNA was applied for quantitation with real-time PCR.
Infection assay
The infection of env-pseudotyped virus into human T-cell
lines were performed essentially as previously described
(25). M8166/H1Luc cells (33), containing HIV-1 LTR-
luciferase vector, were used for single-round infection ex-
periments to determine overall infectivity of virus by Tat
expression. Luciferase activity of cells was determined by
the Bright-Glo luciferase assay system (Promega,
Madison, WI, USA). TRIM5-KD/Luc-KD Jurkat cells
(kind gifts from Dr Jeremy Luban) and MT-4 cells (34)
were used for viral infection and viral DNA quantitation
by real-time PCR assay. 1 10
6 cells per sample were
infected with puriﬁed virus and total cellular DNA was
extracted with GenElute mammalian genomic DNA
miniprep kit (Sigma-Aldrich, St Louis, MO, USA)
at 18h post infection. Equal amount of total DNA was
applied for real-time PCR analysis.
Real-time PCR
Real-time PCR analysis was performed essentially as pre-
viously described (35). For detection of viral RNA from
puriﬁed virion, Gag primers (TM-GagF: GCAGCCATG
CAAATGTTAAAAGAG, and TM-GagR: TCCCCTTG
GTTCTCTCATCTGG) were applied with One Step
SYBR PrimeScript PLUS RT-PCR kit (Takara Bio
Inc.). For detection of viral DNA from MT-4 cells,
primers and Taqman probes were selected according to
criteria described elsewhere (36). For detection of viral
DNA from TRIM5-KD/Luc-KD Jurkat cells, Gag
primers and a probe (NL1359F: AGTGGGGGGACAT
CAAGCAGCCATGCAAAT, NL1500R: TGCTATGTC
AGTTCCCCTTGGTTCTCT, and NLgag1400TqmnFB:
FAM-ATCAATGAGGAAGCTGCAGAATGGGA
-BHQ-1) were applied
RESULTS
Maturation of NC is important for the completion of
genome dimerization
To investigate which cleavage site(s) of HIV-1 Gag protein
is responsible for genomic RNA dimerization, ﬁve single
Gag-cleavage site mutants, MA/CA, CA/p2, p2/NC, NC/
p1 and p1/p6 (Figure 1B) were constructed. Protein
proﬁles of the mutants released from 293T cells were
assessed by Western blotting, using antibodies against
MA, CA, NC and p6 (Figure 1C). The mutant MA/CA
yielded an MA–CA fusion product (p41) and the mutant
CA/p2 yielded a CA-p2 fusion product (p25), as expected.
Only a faint band corresponding to the p2-NC fusion
product (p9) was observed in the p2/NC mutant and a
strong signal was observed as the p32 or p33 intermediate,
which was consistent with a previous report (17). This can
be considered as an aberrant product comprised by
CA-p2-NC fusion protein and may be due to the block
of the primary cleavage at p2/NC of Gag, resulting in an
aberrant exhibition of other cleavage sites to PR leading
to insufﬁcient processing. However, there was also a clear
CA protein signal on anti-CA blot in the p2/NC mutant
(Figure 1C). As the CA/p2 junction must be cleaved for
CA release, it is reasonable to assume that a certain
amount of p2-NC protein existed in the mutant. The
faint signal from the p9 on the anti-NC blot would
suggest that the antibody recognition epitope of NC is
somehow masked on the p2-NC fusion protein. The Asn
to Thr substitution (amino acid #432) in the mutant NC/
p1 was located just proximal to the heptameric slippery
sequence, UUUUUUA, where the programmed riboso-
mal frame shifting for Gag-Pol precursor translation
occurs (37). Nonetheless the heptameric sequence itself
was conserved completely, the mutation introduced was
expected to have little effect on frame shifting. The
mutant NC/p1 actually yielded p9 properly. The mutant
p1/p6 yielded a p1–p6 fusion product (p8) and the substi-
tution did not affect the peptide sequence of Pol protein.
Taken together, all the mutations expressed as expected.
3408 Nucleic Acids Research, 2011,Vol.39, No. 8To evaluate the genome RNA dimer stability of these
single cleavage site mutants, genomic RNA isolated from
mutant virions were incubated at various temperatures
and their thermostability was examined with native
northern blot analysis (Figure 2A). Genomic RNA was
mainly observed as a dimer at 25 C in all mutant virions
except for the PR mutant (Figure 2C). The amounts of
monomeric RNA for the p2/NC and NC/p1 mutants at
25 C were slightly higher than WT (NLNh) (Figure 2C
and D). On the other hand, the amounts of monomers for
the other mutants (MA/CA, CA/p2 and p1/p6) were
similar to that of WT from 25 Ct o4 4  C. These results
indicated that both cleavage sites at the NC termini are
important for genomic RNA dimerization. It is also
possible that insufﬁcient Gag-cleavage of the p2/NC
mutant might contribute to the relatively low stability of
its dimeric genome.
The mutants to mimic cleavage intermediates of Pr55
It was previously demonstrated that the processing rates
of the ﬁve Pr55 cleavage sites were not equal (38). The
processing rate of the cleavage site between p2 and NC
(p2/NC) is the fastest, while p1/p6 and MA/CA are second
and the third, respectively. The processing rates of the two
remaining sites are much slower than those of the three
sites mentioned above. Although the results from single
cleavage site mutants (p2/NC and NC/p1) showed the
importance of NC in RNA dimerization (Figure 2), such
composition of intermediate proteins would hardly appear
during native virion maturation. As virion maturation is
suggested to occur during or immediately after virion
budding (39,40), it is very difﬁcult to observe this matur-
ation process in a time series. Therefore, four sequential
HIV-1 Gag mutants were constructed (Figure 3A) in an
attempt to generate a sequential series of Gag maturation
intermediates and to help study the RNA dimer transition
from fragile to stable, which occurs in virions during mat-
uration. Step0 carries all cleavage site mutations and its
Pr55 would not be processed by PR. The mutants Step1,
1.1 and 2 carried four, three and two cleavage site muta-
tions, respectively. Thus, these sequential mutants were
expected to mimic the maturation process of Gag in a
step-wise manner. All mutations were conﬁrmed to yield
expected fusion proteins, respectively by western blotting
analysis (Figure 3B). Step0 mostly expressed unprocessed
Pr55. Step1 contained p41 and p15 fusion proteins,
Step1.1 contained p41 and p9 fusion proteins, and Step2
contained p25 and p9 fusion proteins.
When genomic RNA isolated from the sequential
mutants was examined by native northern blotting, the
sequential mutants contained a higher rate of monomeric
genomes than the WT (Figure 3C and D). The genomic
RNA from Step0 was exclusively monomeric, similar to
the PR. The monomer rate of Step1, where Gag was
cleaved only at p2/NC, was dramatically reduced
(<40%) in comparison to that of Step0, and was compar-
able to the rate of Step1.1. Viral genomes from immature
particles were observed as monomers on a native gel, and
were proposed to be unstable and fragile dimers (13).
These results suggested that the initial cleavage of Gag,
which processes p2/NC, was critical for genomic RNA
dimer stabilization in HIV-1. The monomer rate of the
Step2 was gradually reduced to  25%, but still higher
than that of WT. Finally, the CA/p2 mutant showed a
similar level of monomer content to WT. Taken
together, viral genome dimerization showed triphasic
states during virion protein maturation.
Consecutive Gag processing is required for genome dimer
maturation
As shown in Figure 3, our data indicated that the propor-
tions of genomic RNA dimers in the Step1 and 1.1
mutants were similar, but we did notice that their RNA
proﬁles were not completely identical. To compare the
RNA proﬁles of these samples more precisely, we
scanned the RNA signals on the blot and densitometric-
ally analyzed their distribution (Figure 4). We ﬁrst focused
on the peak position of RNA dimer in each mutant
(Figure 4B). The mobility of the dimer in Step1 was con-
siderably lower than that of WT, suggesting its apparent
molecular mass to be relatively high. The peak mobility of
Step1.1 and 2 were slightly lower than the mobility of WT,
while the dimer mobility of CA/p2 and NC/p1 mutants
were very similar to WT. We then examined the RNA
signal distribution pattern of the mutants on the blots
(Figure 4C) When genomic RNA were analyzed on the
gel under native conditions (35 C), an intense signal of
monomeric RNA from PR mutant formed a sharp
peak, although it was preceded by a smaller peak at the
dimer position. The RNA signal of Step0 formed the
highest peak at the same position as PR and overall
signal distributions looked very similar. Interestingly,
Step1 formed a broader RNA signal range in comparison
to WT. Although the peak signal was detected at the
dimer position, the mobility was shorter and signal inten-
sity was relatively weak. Additional signals were observed
at larger molecule areas than the normal dimer and at a
monomer position. The RNA signal of Step1.1 formed the
highest peak at the dimer position, with a modest intensity
at the monomer area, which was also observed for Step1.
The signal pattern of Step2 was similar to that of Step1.1,
but with reduced signals at the monomer area. The signal
of CA/p2 mutant was almost the same shape as that of
WT, whereas that of NC/p1 was more aberrant and analo-
gous to that of Step1, but the peak signal of dimer was
more concentrated. These results suggested that p2/NC
processing alone was not sufﬁcient to complete the dimer-
ization of genomic RNA at WT levels and the ensuing
cleavages were also required to change the genome into
uniform dimers.
Stoichiometric analysis of Gag processing and RNA
dimerization
The results presented in Figure 3 revealed that p2/NC
processing was the most important step for stable
dimeric RNA formation. This suggested that the progres-
sion of the initial Pr55 cleavage would stimulate the
genomic RNA maturation. To investigate the extent of
the required processing, and whether a threshold for the
RNA dimerization switch from fragile to stable exists, we
Nucleic Acids Research,2011, Vol.39, No. 8 3409Figure 4. Dissection of RNA proﬁles of the mutants in native condition. Phosphorimage of RNA incubated at 35 C was taken, its signal intensity
distribution analyzed and represented by the line chart. (A) Raw RNA proﬁles from northern blot. (B) Mobility of peak signals of monomeric RNA
(Step0 and PR) or dimeric RNA (others). (C) The RNA proﬁle transition from immature (PR or Step0) to mature (WT) conditions. The proﬁle
of WT was drawn as shaded charts in each graph. Signal intensities were measured at every 0.01mm and total value of each signal was set to one.
The plotted data are the value at every 0.5mm. The data are the average of three separate experiments, and the error bars represent SEM.
3410 Nucleic Acids Research, 2011,Vol.39, No. 8attempted to snapshot the initial virion maturation
process of HIV-1 through co-transfection. The ratios of
Step1 to Step0 were changed from 10:0 to 0:10 successively
by mixing two plasmids for co-transfection and the series
of resultant viral particles were harvested. The monomeric
viral genome content from various particles were
visualized and analyzed by northern blot (Figure 5A).
The graph represents the relationship between monomeric
genome content and proportion of processed Gag (Step1)
within the virion (Figure 5B), and the data were ﬁt to a
linear regression model (R
2&0.956). These results
indicated that the increase of cleavage products may not
have a threshold for the transition from monomeric to
dimeric RNA genomes.
Virion morphology and genome dimerization
It is well-known that HIV-1 virion morphology dramatic-
ally changes during Pr55 processing. To investigate
whether the morphological changes of the virion are
correlated with genomic RNA dimerization, virion mor-
phological features of the four sequential step mutants
and NC/p1 mutant were observed with electron micros-
copy (Figure 6). Virion morphologies were classiﬁed into
four main groups (Figure 6A) and morphological classiﬁ-
cations were based on viral core and membrane conditions
(Table 1). The morphology of all PR virions were typical
immature particles (Group A) as demonstrated by many
previous reports [e.g. (41)]. As expected, virions from the
Step0 mutant were very similar to those of PR,
containing a thick electron-dense ring and devoid of a
conical-shaped core, termed a doughnut-shaped morph-
ology. The morphologies of the WT, as well as the NC/
p1 virions, were classiﬁed into two major groups. One was
the typical mature particle (Group D), with a conical core
surrounded by an envelope (Figure 6A). The second was
an enveloped particle containing some amorphous struc-
tures rather than an obvious core (Group C). Most of the
virions from Step1 and 1.1 were immature (Group B), but
did not have an apparent electron-dense ring like Group A
particles, with envelopes that were thicker than those of
Group C. The virions from Step2 contained both Group B
Figure 6. Virion morphology of the mutants. (A) Classiﬁcation of
virion morphology judged by electron microscopy analysis. The criter-
ion for judgment was summarized in Table 1. (B) The distribution chart
of virion morphology in each mutant. A minimum of one hundred
particles were surveyed and classiﬁed for each mutant.
Figure 5. Stoichiometric analysis of Gag processing and RNA dimer-
ization. PR mutant plasmid and the mixtures of Step0 and 1 plasmids
were applied for transfection, and a series of resultant viral particles
were harvested. The ratios of Step 1 to Step 0 was changed successively
from 10:0 to 0:10. (A) Virion RNA proﬁles were detected by northern
blotting in a native agarose gel as in Figure 2. (B) The monomer
content of each RNA in native condition was calculated and repre-
sented by a scatter diagram. The data are the average of three inde-
pendent experiments and the error bars represent SEM. The formula
and R-squared value of the straight-line approximation are shown.
Table 1. Classiﬁcation of virion morphology based on
electron-microscopic observation
Group Core Envelope
A Ring-shaped Thick
B Amorphous Thick
C Amorphous or non-conical Thin
D Conical Thin
Nucleic Acids Research,2011, Vol.39, No. 8 3411and C particles. We classiﬁed the virions from each step
into groups and drew a chart to represent the morpho-
logical transition of the HIV-1 virion during maturation
(Figure 6B). These results indicated that dimer stabiliza-
tion of the HIV-1 genome, occurring at the timing of
p2-NC cleavage, was consistent with the start of virion
morphological change from Group A to B, but not with
viral core formation.
Endogenous RT activity, infectivity and maturation
process
Although the maturation process is required for virion
infectivity, the sequential steps to acquire infectivity,
remains unclear. To identify the maturation step which
prepares viral RNA ready for reverse transcription, the
endogenous RT activity of the mutant virions were
assessed. The virions were puriﬁed from transfectant
supernatants, re-suspended in PBS ( ) then incubated
with detergent and dNTPs. The amount of viral DNA
was determined by real-time PCR with two sets of
primers, R/U5 (early products) and 2ndTfr (late
products) (Figure 7). The RT product of Step0 was
reduced by one order of magnitude when compared to
WT for the early products, and was attenuated by more
than two orders for the late products. Step1 RT products
were increased by 2- to 3-fold in both at early and late RT
stages. A gradual reduction in the amount of viral DNA
was observed, which eventually reached WT levels by the
fourth cleavage event (CA/p2 mutant). These data
indicated that the initial Pr55 cleavage prepares the viral
RNA for RT within virion. The enzymatic activity of viral
reverse transcriptase was conﬁrmed by exogenous RT
assay. All mutants, with the exception of PR, showed
similar RT activity as the WT (data not shown).
We ﬁnally compared the infectivity of the mutants in
T-cell lines. Single-round virus infectivity assays using
marker cells (M8166/H1Luc) revealed that only the CA/
p2 mutant showed similar infectivity to WT (Figure 8A).
We performed real-time PCR analysis of viral DNA
within infected cells (MT-4) to determine when the
defect occurred during virion maturation (Step1, 1.1 and
2), and located the defect at a step before and/or early-RT
(Figure 8B). The TRIM5alpha protein (T5a) restricts
retrovirus infection during the uncoating process prior
to the initiation of RT (42). Although human T5a is sug-
gested to have little anti-HIV-1 effect, immature virions,
may be affected by it. To determine the effect of human
T5a on the mutants, T5a knock-down (KD) and control
cells were applied for infection assay (Figure 8C). The
viral DNA production in both cells was very similar, sug-
gesting no participation of T5a restriction with immature
virions.
DISCUSSION
We have described a sequential mutational analysis series
of the HIV-1 Gag cleavage sites to clarify the relationship
between virion maturation and genome RNA dimeriza-
tion, adding further mechanical insight into previously
reported observations.
The results from the ﬁve single cleavage site mutants in
Figures 1 and 2 showed that NC/p1 site as well as p2/NC
is involved in genomic RNA dimerization, which is con-
sistent with previous studies (17,18). NC maturation,
indicated by the release of NC from p2 and p1, would
be a critical factor for genomic RNA dimerization. NC
has been reported to convert fragile RNA dimers into
stable dimers in a cell-free system, suggesting that NC is
an important contributor to RNA dimer formation (43).
The partially processed NCs, p2-NC and NC-p1, may
have attenuated RNA dimerization properties, indicated
by the failure to form normal RNA dimers and leaving
them in an unstable state. The dissociation temperature of
the RNA dimer in our experiments,  45 C, was relatively
low in comparison to those in other studies (18,44,45).
This might be due to the subtle differences in assay con-
ditions, such as the presence of formamide in RNA buffer.
The examination of genomic RNAs derived from four
sequential mutants showed many interesting results
(Figure 3). The RNA from Step0 mutant was very
similar to that from PR. This result clearly shows that
Pr55 cleavage, and not PR activity itself, is required for
RNA maturation. Although PR and Step0 mutant show
immature RNA phenotype, the blots change with
increasing temperature. The RNA in the PR have been
suggested to form fragile dimers (13). In addition, the
retroviral RNA in the virion contains many nicks
Figure 7. The endogenous RT activity in the virions of mutants. The
original values are calculated by dividing the viral DNA amount by the
viral RNA amount in virions. Relative amount to WT of early (R-U5:
A) and late (2nd Tfer :B) products of RT are shown. The data are the
average of at least three independent experiments, and the error bars
represent SEM. The statistical signiﬁcance was evaluated by a Student’s
t-test. *P<0.05; **P<0.01.
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Step0 RNA in native condition partially forms fragile
dimers, and it gradually dissociate and is dissected in frag-
ments to be smeared signals as the temperature rises.
The blot also indicated that the main transition of the
RNA from a monomer to a dimer state occurred between
the Step0 and Step1 mutants (Figure 3). Pr55 Gag is ini-
tially cleaved by PR into intermediate proteins p41
(MA-CA-p2) and p15 (NC-p1-p6). Previous reports
showed that p15, as well as NC of HIV-1, interacted
with in vitro synthesized viral RNA, and GST-fused re-
combinant p15 protein efﬁciently induced dimerization of
viral RNA fragments (47,48). Our results showed that p15
also promoted genomic RNA dimerization in a nascent
virion. A recent report showed the nucleotide binding
ability of Pr55 Gag was  10-fold higher than NC
proteins (p15, p9 and NC), while its destabilizing effect
on double-stranded nucleotides was much lower than the
NC proteins (49). Taken together with our results, we
assumed that the primary processing of Pr55, which is
anchored to the viral inner membrane during virion
assembly, would release p15 within the virion. Then the
tight, non-speciﬁc binding between nucleotide and Pr55 is
relieved, enabling the NC region of p15 to interact with
the proper sites on genomic RNAs to initiate dimer
maturation.
The melting temperature (Tm) of RNA from Step2 seems
similar to those of Step1/1.1, although the monomer
contents are different. We regard that the thermal stability
of ‘already dimerized’ RNA in the mutants are similar
regardless of dimer formation efﬁciency. Thus the
thermal dissociation curve of the mutants would be
converged to present similar Tm.
The molecular mass of dimerized genomic RNA
isolated from the Step1 mutant included larger and
smaller components than WT (Figure 4). We propose
two hypotheses on this observation. First, non-viral
RNAs may interact with the detected genomic RNA
dimer. Previous reports have suggested that in addition
to viral genomes, non-selective RNAs derived from the
host cell are packaged in virions (50,51). It is possible
that p15 from the Step1 mutant is somewhat different
from p9 or WT NC in its ability to recognize its proper
viral RNA target. Thus, the slower-migrating complex
detected in the Step1 mutant may be composed of
genomic RNAs and other non-viral RNAs. Second,
genomic RNA dimers in the Step1 mutant may be in a
relaxed conformation. It has been often observed that
Figure 8. The infectivity of the mutants into T-cell lines. (A) Overall infectivity into M8166/H1Luc cells. (B) Viral DNA production measured by
real-time PCR assay within infected cells (MT-4) 18h post-infection. (C) Viral DNA production within TRIM5alpha
+/  Jurkat cells. In each ﬁgure,
the value of WT is set as one. The data are the average of at least three independent experiments, and the error bars represent SEM.
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native gel (e.g. see 44 C lanes of NLNh in Figure 2A),
which is considered to be the reason why RNA dimers
are relaxed by thermal energy. In either case, ensuing
Gag processing and resultant NC maturation would lead
to the proper dimerization of genomic RNA and acquire
infectivity. As the viral RNA from Step1.1 no longer con-
tained larger components, p15 processing into p9/p6
might play a role(s) to form tight dimers. These results
suggested the complexities of dimer maturation and were
consistent with the recent report describing a three-step
dimerization process of the HIV-1 genome (52).
Some unexpected results were obtained from the
stoichiometrical analysis of Gag processing and RNA di-
merization (Figure 5). We ﬁrst considered the uniformity
of the ‘chimeric’ virion. There could be an argument
whether what we are observing is a changing proportion
of two distinct populations of homo-multimeric particles
or whether the particles are becoming individual, chimeric
virions. Thus we showed the model of virus particle com-
position here. To simplify the model, we ﬁrst imposed
precondition: that one particle includes 1000 molecules
of Gag and the two species of Gag (Step0 and Step1) dis-
tributes evenly within the cell. The particle assembly
driven by the Gag proteins follows a binomial distribution
manner. Under these conditions, the calculations sug-
gested that  99.9% of the particle includes 450–550 Gag
of each species if the ratios of two species are 1:1. Similar
results are obtained in various ratios. This outcome
strongly suggests that most of the particle composition
reﬂects the mixed ratio of the plasmids applied for trans-
fection. Thus, we believe the data in Figure 5 represents
the RNA status of a chimeric virion.
It has been suggested that NC protein has RNA chap-
erone activity and one NC molecule/20nt would be sufﬁ-
cient for promoting viral RNA dimerization (43). Thus,
we assumed that there should be a p15 molecular concen-
tration threshold imposed on the dimer transition from
fragile-to-stable during Pr55 processing. It is reasonable
to consider that a certain accumulation of processed Gag
would trigger dimer stabilization. However, as in Figure 5,
‘intermediately-processed’ virions packaged stable and
unstable dimers about equally. This means that even
within the same virion protein composition, a population
undergoing genome dimer stabilization encountered a sto-
chastic decision process. To explain this observation, we
present one working theory in Figure 9. Since NC displays
both non-speciﬁc and speciﬁc RNA binding, it has been
proposed that NC ﬁrst interacts with the packaging signal
and then additional NC domains coat the viral RNA in a
sequence-independent manner. The binding ability of NC
to RNA has been suggested to be generally in the range of
1 protein molecule per 5–7 nucleotides. (53–55). Thus
around 2500–4000 NCs would be required to coat the
entire dimeric retroviral genome, which is approximately
9000 nucleotides per strand. Because a retroviral virion is
suggested to be composed of about 2500–5000 Gag mol-
ecules according to the latest reports (56,57), the quantity
of NC proteins in a virion is not in excess, but in rather
adequate numbers for a dimerized genome. As some
reports have suggested (31,58,59), there is a possibility
that additional dimer contact points on viral RNA other
than the DLS, which mediate mature ribonucleoprotein
complex formation within virion, may exist. Here, we
assume that there are several such points on each
genome (Figure 9A) and NC proteins binding to these
points were simply non-speciﬁc and random, such as
binding to normal nucleotides. In the fully-processed
virions (Step1; Figure 9B, right), all the points are
coated with sufﬁcient NC and produced the stable dimer
formation. Conversely, if no points are bound with NC,
the dimeric genome would remain fragile in immature par-
ticles, like particles from the Step0 or PR mutants
(Figure 9B, left). In the case of ‘intermediately-processed’
particles, like the virions produced from the Step0–Step1
mixtures, the dimers could be both fragile and stable. As
NC (p15) numbers are not sufﬁcient in such particles, the
genomes would be only partially covered by NC. If NCs
covered the contact points on the genomes and properly
mediated the RNA–RNA interaction, the dimer would be
stable (Figure 9C, right). On the other hand, if NCs failed
Figure 9. Schematic hypothetical models of virion and genome dimer-
ization in various maturation conditions. (A) A diagram of a viral
genome carrying one DLS and putative ‘dimer contact points (DCP)’
(B) Images of matured (right) and immature (left) virions. (C) Images
of ‘intermediately-matured’ virions. Although both genomes were only
partially covered with NC, the particle on left fails to form a stable
genome dimer, whereas the particle on the right forms a stable dimer.
The dimerization efﬁciency depends on the extent of coverage of DCP
by NC. Solid lines represent viral RNA, Shaded circles represent DLS
on the RNA, Open circles represent hypothetical DCP, and dotted
squares represent NC (p15).
3414 Nucleic Acids Research, 2011,Vol.39, No. 8to cover the points correctly, the dimer formation would
remain fragile (Figure 9C, left).
Electron microscopy analysis of the sequential cleavage
site mutants showed successive morphological changes
during Pr55 Gag maturation (Figure 6). Virions classiﬁed
into Group A were <10% from Step0 to Step1, and most
of the remaining virions changed to Group B, another
immature particle classiﬁcation. As the change from
Group A to B was characterized by disappearance of an
electron dense ring inside the viral membrane, the
observed ring could be composed by the p15 region
within Pr55. After the cleavage at p2-NC position, the
ordered array of the p15 region would be lost and p15
would be released from perimembrane. This transition
was synchronous with initial dimeric RNA stabilization,
suggesting the release of genome RNA from a
perimembrane localization to a space inside the virion
where p15 would trigger dimer maturation. The cleavage
at p1–p6 (from Step 1 to 1.1) did not affect virion morph-
ology, although this process contributed to a uniformly
dimerized genome (Figure 4). The thin-membraned
virions (Group C) became abundant after the third pro-
teolytic processing at the MA/CA region, represented by
the Step2 mutant. A certain portion of Group C particles
could easily contain the conical cores of Group D, which
are meant to be matured virions, but cut transversely the
morphology can appear different. Nonetheless half of
Step2 mutant particles were classiﬁed into Group B and
thus showing unique morphology. Viral membranes of
Group B may appear to be thick because of Pr55 CA
region fusion to MA, which lines the inner membrane. It
has been speculated that viral dimeric RNA could mature
in the absence of the viral core (44). Our study not only
conﬁrmed this hypothesis, but additionally revealed that
RNA maturation would begin and approach completion
before core formation in the virion. In addition, although
morphological proportion of the virions produced from
the NC/p1 mutant was almost similar to WT
(Figure 6B), genome dimerization in the NC/p1 mutant
was less efﬁcient than in WT (Figure 2). This suggests that
proper core formation alone may be insufﬁcient to fully
accomplish RNA maturation. Taken together, particle
morphology dynamics during viral maturation did not
clearly synchronize with the transition of dimeric RNA
status.
The processing speed of the NC-p1 cleavage site in vitro
has been suggested to be very low and nearly equal to that
of CA-p2 (38). This observation leads to the idea that an
intermediary such as the NC/p1 mutant could be
generated as much as the CA/p2 mutant during the ﬁnal
phase of virion maturation. However, the data from viral
RNA proﬁles (Figures 2 and 4) indicated that NC/p1
mutant contained aberrant RNA and could not support
infection. In contrast, the RNA proﬁles or infectivity of
CA/p2 mutant were very similar to WT. In addition, CA/
p2 mutant has been reported to contain tightly condensed
internal RNP cores with a size and morphology similar to
those of WT particles (16). These observations imply that
CA-p2 cleavage, but not NC-p1 cleavage, would occur
during the ﬁnal phase of virion maturation. This insight
might be explained by the ﬁndings of the recent paper (60)
which presented the stimulation of p15 (NC-p1-p6)
cleavage by PR in the presence of ssRNA/DNA. Due to
a simple biochemical assay which ignored the existence of
ssRNA genome interacting with most of Pr55 molecules,
the processing rate of NC-p1 site within the virions may be
underestimated.
The infectivity assay of the mutants unveiled very
intriguing results. The endogenous RT activity of viral
RNA in the virion was fully detected following the
initial cleavage of Pr55, whereas the production of viral
DNA in the infected cell was not observed until comple-
tion of NC maturation. These results suggested that
although viral RNA was fully active as the template for
viral reverse transcriptase just after initial cleavage of the
precursor, much more virion maturation processes were
required for the RT of viral RNA within cells. We form
two possibilities to explain these results. One is the exist-
ence of cellular restriction system to eliminate immature
viral RNA just after the penetration into the cytoplasm.
As the restriction activity was not mediated by human T5a
(Figure 8C), we assume it could be cytoplasmic RNases or
some other enzymes to corrupt RNP of virus. The second
possibility is a defect in penetration into the host cell by
the mutant. As the most of the mutants failed to form
proper virion structure, there may be some defects in the
release of RNP into the cells somewhere during viral
fusion and uncoating. However, when we examined the
infectivity of NC/p1 mutant, we found that NC/p1
produced only <10% early viral DNA in infected cell in
comparison to WT (data not shown). As virion morph-
ology of the NC/p1 mutant is nearly similar to the WT
(Figure 6B), the uncoating defects of the mutants alone
may not fully explain this difference.
In the in vitro assay, p9 or p15 proteins, which are
immature NC intermediates, were suggested to obtain in-
sufﬁcient RNA chaperone activity required for strand
transfer during reverse transcription (49). Although our
results of the endogenous RT assay were not consistent
with the study, different experimental conditions can offer
partial explanation to this discrepancy. As the samples
applied for the endogenous RT assay are puriﬁed
virions, many viral/host factors are present within the
assay conditions and would participate in the reaction.
In summary, we suggested here that mature NC or the
intermediate proteins containing NC region are involved
in genomic RNA dimerization within the HIV-1 particle.
Dimer stabilization begins during the primary cleavage
(p2-NC) of Pr55 Gag. However, the primary cleavage
alone is not sufﬁcient for completion of dimerization
and ensuing cleavages are required to generate a stable
and uniform dimer. The majority of this process does
not require a mature viral core. In contrast, the primary
cleavage is more than enough to initiate endogenous RT
activity of viral RNA, whereas overall viral infectivity, as
well as intracellular viral DNA production, required the
near-completion of viral maturation.
Other retroviruses also have NC and dimeric RNA
genomes, suggesting that RNA dimerization could occur
in the same manner as HIV-1. Future studies with HIV-1
or other retroviruses will contribute to clarify the general
Nucleic Acids Research,2011, Vol.39, No. 8 3415and speciﬁc roles and mechanisms of retroviral RNA di-
merization, which continues to be an age-old problem.
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